医院排行榜需守4条线

2018-07-20 李琳 健康报

7月19日,在于上海市召开的医疗技术能力和医疗质量水平双提升专题新闻发布会上,国家卫生健康委员会医政医管局副局长郭燕红指出,目前社会上针对医院的各种排行榜名目繁多,但在关注领域、采信数据、评价方法和发挥作用等方面差异性较大,还需规范。

7月19日,在于上海市召开的医疗技术能力和医疗质量水平双提升专题新闻发布会上,国家卫生健康委员会医政医管局副局长郭燕红指出,目前社会上针对医院的各种排行榜名目繁多,但在关注领域、采信数据、评价方法和发挥作用等方面差异性较大,还需规范。

郭燕红强调,医院医疗质量排行榜也应着眼于差距所在、问题所在,形成医疗机构不断进取、攀登高峰的动力。医疗质量排行榜是否符合4个要素,是国家卫生健康行政部门的重点关注。首先,排名是否能发挥对医疗机构正向引导和激励作用,是否通过排名引导医疗机构关注医疗质量和技术能力的提升工作;其次,排名所采用的指标体系是否科学、合理和客观;第三,排名采信的数据信息是否可靠,包括数据信息的准确性、完整性等;第四,信息和数据收集过程是否安全,收集单位是否能够维护好病人的信息安全,是否有良好的整理、分析和统计的能力。



版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1495571, encodeId=6b5714955e1a1, content=<a href='/topic/show?id=92745665668' target=_blank style='color:#2F92EE;'>#排行#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56656, encryptionId=92745665668, topicName=排行)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb39173897, createdName=wujh_7312822, createdTime=Sun Jul 22 08:36:00 CST 2018, time=2018-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332966, encodeId=e412332966d4, content=没必要, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Fri Jul 20 20:49:53 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332958, encodeId=d340332958fd, content=学习了,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Jul 20 20:11:19 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332940, encodeId=99ba332940c4, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Fri Jul 20 17:43:25 CST 2018, time=2018-07-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1495571, encodeId=6b5714955e1a1, content=<a href='/topic/show?id=92745665668' target=_blank style='color:#2F92EE;'>#排行#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56656, encryptionId=92745665668, topicName=排行)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb39173897, createdName=wujh_7312822, createdTime=Sun Jul 22 08:36:00 CST 2018, time=2018-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332966, encodeId=e412332966d4, content=没必要, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Fri Jul 20 20:49:53 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332958, encodeId=d340332958fd, content=学习了,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Jul 20 20:11:19 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332940, encodeId=99ba332940c4, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Fri Jul 20 17:43:25 CST 2018, time=2018-07-20, status=1, ipAttribution=)]
    2018-07-20 医者仁心5538

    没必要

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1495571, encodeId=6b5714955e1a1, content=<a href='/topic/show?id=92745665668' target=_blank style='color:#2F92EE;'>#排行#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56656, encryptionId=92745665668, topicName=排行)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb39173897, createdName=wujh_7312822, createdTime=Sun Jul 22 08:36:00 CST 2018, time=2018-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332966, encodeId=e412332966d4, content=没必要, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Fri Jul 20 20:49:53 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332958, encodeId=d340332958fd, content=学习了,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Jul 20 20:11:19 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332940, encodeId=99ba332940c4, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Fri Jul 20 17:43:25 CST 2018, time=2018-07-20, status=1, ipAttribution=)]
    2018-07-20 惠映实验室

    学习了,谢谢分享。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1495571, encodeId=6b5714955e1a1, content=<a href='/topic/show?id=92745665668' target=_blank style='color:#2F92EE;'>#排行#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56656, encryptionId=92745665668, topicName=排行)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb39173897, createdName=wujh_7312822, createdTime=Sun Jul 22 08:36:00 CST 2018, time=2018-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332966, encodeId=e412332966d4, content=没必要, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Fri Jul 20 20:49:53 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332958, encodeId=d340332958fd, content=学习了,谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Jul 20 20:11:19 CST 2018, time=2018-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332940, encodeId=99ba332940c4, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Fri Jul 20 17:43:25 CST 2018, time=2018-07-20, status=1, ipAttribution=)]
    2018-07-20 1e145228m78(暂无匿称)

    学习了,谢谢作者分享!

    0

相关资讯

2.5亿精神病患的生存现状:离不开的医院 回不去的家

顺着病房窗户望去,家就在不远处,但不知从哪刻起,他们回不去了。精神病患者,永远是在人们恐惧眼神下绕行的一群人。今年5月25日,国家卫健委疾病预防控制局在呼和浩特市召开全国严重精神障碍管理治疗工作总结部署会暨培训班,会上公布了最新数据,截至2017年底,全国13.9008亿人口中精神障碍患者达2亿4326万4***,总患病率高达17.5%;严重精神障碍患者超1600万人,发病率超过1%,这一数字

药师把关医生处方 这三家医院早就走在了前面

将问题拦截在处方交到患者之前,是很多医院共同的努力方向。如今,不少医院门急诊量每天可达1万人次左右,药师工作量大,很难及时处理全部处方问题。在这种情况下,利用信息化手段对处方进行严格的“人工干预”,尤其是事前干预显得尤为必要。7月10日,国家卫健委公布《医疗机构处方审核规范》,其中规定,医疗机构应当积极推进处方审核信息化,辅助药师开展处方审核。事实上,早在该文件下发前,在应用互联网技术改善药事管

一致性评价,又新增87家临床医院

昨日,国家药监局发布《药物临床试验机构资格认定检查公告(第1号)(2018年第47号)》,认定87家医疗机构具有药物临床试验机构资格。

血栓通、血塞通被限!一批医院不能用

昨日,国家药监局发文,决定修订血塞通注射剂和血栓通注射剂两药品说明书,提出儿童禁用,应在有抢救条件的医疗机构使用。

医院信息化建设为新时代医疗赋能

如何让广大人民群众享有公平可及、系统连续的预防、治疗、康复、健康促进等健康服务,考量着新时代的医疗发展。

国家卫健委对各类医院排行榜提要求啦

“名目繁多的医疗机构排行榜应该引导医疗机构更关注医疗质量和技术能力的提升,而不是引导不合理的患者流动。” 7月19日,在“医疗技术能力与医疗质量水平双提升”上海主题新闻发布会上,国家卫健委医政医管局副局长郭燕红针对各类排行榜提出四点要求。如今,各类针对医院的排名或排行榜名目繁多。郭燕红对此表示,这些排名在关注的领域、应用的指标,特别是采信的数据、评价的方法、发挥的作用等几个方面差异性较大。众所周